Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice

S. George, S. D. Kadam, N. D. Irving, G. J. Markowitz, S. Raja, A. Kwan, Y. Tu, H. Chen, Charles A Rohde, D. R. Smith, Anne Marie Spalding Comi

Research output: Contribution to journalArticle

Abstract

Stroke in the neonatal brain frequently results in neurologic impairments including cognitive disability. We investigated the effect of long-term sodium valproate (valproate) and Trichostatin A (TSA) treatment upon post-stroke neurogenesis in the dentate gyrus (DG) of stroke-injured immature mice. Decreased or abnormal integration of newborn DG neurons into hippocampal circuits can result in impaired visual-spatial function, abnormal modulation of mood-related behaviors, and the development of post-stroke epilepsy. Unilateral carotid ligation of P12 CD1 mice was followed by treatment with valproate, TSA, or vehicle for 2 weeks, BrdU administration for measurement of neurogenesis, and perfusion at P42 or P60. Behavior testing was conducted from P38-42. No detrimental effects on behavior testing were noted with TSA treatment, but mildly impaired cognitive function was noted with valproate-treated injured animals compared to normal animals. Significant increases in DG neurogenesis with both TSA and valproate treatment were noted with later administration of BrdU. Increased mortality and impaired weight gain was noted in the valproate-treated ligated animals, but not in the TSA52 treated animals. In summary, the impact of HDAC inhibition upon post-stroke SGZ neurogenesis is likely to depend on the age of the animal at the time point when neurogenesis is assessed, duration of HDAC inhibition before BrdU labeling, and/or the stage in the evolution of the injury.

Original languageEnglish (US)
JournalFrontiers in Cellular Neuroscience
Issue numberJUL
DOIs
StatePublished - Jul 13 2013

Fingerprint

trichostatin A
Neurogenesis
Valproic Acid
Stroke
Dentate Gyrus
Bromodeoxyuridine
Cognition
Nervous System
Weight Gain
Ligation
Epilepsy
Perfusion
Neurons
Mortality
Wounds and Injuries
Brain

Keywords

  • Anticonvulsants
  • Behavioral outcomes
  • Hippocampal neurogenesis
  • Histone deacetylase inhibitors
  • Neonatal stroke
  • Trichostatin A
  • Valproate

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice. / George, S.; Kadam, S. D.; Irving, N. D.; Markowitz, G. J.; Raja, S.; Kwan, A.; Tu, Y.; Chen, H.; Rohde, Charles A; Smith, D. R.; Comi, Anne Marie Spalding.

In: Frontiers in Cellular Neuroscience, No. JUL, 13.07.2013.

Research output: Contribution to journalArticle

George, S. ; Kadam, S. D. ; Irving, N. D. ; Markowitz, G. J. ; Raja, S. ; Kwan, A. ; Tu, Y. ; Chen, H. ; Rohde, Charles A ; Smith, D. R. ; Comi, Anne Marie Spalding. / Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice. In: Frontiers in Cellular Neuroscience. 2013 ; No. JUL.
@article{f6d52fea88754e1a81a51d06077a4596,
title = "Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice",
abstract = "Stroke in the neonatal brain frequently results in neurologic impairments including cognitive disability. We investigated the effect of long-term sodium valproate (valproate) and Trichostatin A (TSA) treatment upon post-stroke neurogenesis in the dentate gyrus (DG) of stroke-injured immature mice. Decreased or abnormal integration of newborn DG neurons into hippocampal circuits can result in impaired visual-spatial function, abnormal modulation of mood-related behaviors, and the development of post-stroke epilepsy. Unilateral carotid ligation of P12 CD1 mice was followed by treatment with valproate, TSA, or vehicle for 2 weeks, BrdU administration for measurement of neurogenesis, and perfusion at P42 or P60. Behavior testing was conducted from P38-42. No detrimental effects on behavior testing were noted with TSA treatment, but mildly impaired cognitive function was noted with valproate-treated injured animals compared to normal animals. Significant increases in DG neurogenesis with both TSA and valproate treatment were noted with later administration of BrdU. Increased mortality and impaired weight gain was noted in the valproate-treated ligated animals, but not in the TSA52 treated animals. In summary, the impact of HDAC inhibition upon post-stroke SGZ neurogenesis is likely to depend on the age of the animal at the time point when neurogenesis is assessed, duration of HDAC inhibition before BrdU labeling, and/or the stage in the evolution of the injury.",
keywords = "Anticonvulsants, Behavioral outcomes, Hippocampal neurogenesis, Histone deacetylase inhibitors, Neonatal stroke, Trichostatin A, Valproate",
author = "S. George and Kadam, {S. D.} and Irving, {N. D.} and Markowitz, {G. J.} and S. Raja and A. Kwan and Y. Tu and H. Chen and Rohde, {Charles A} and Smith, {D. R.} and Comi, {Anne Marie Spalding}",
year = "2013",
month = "7",
day = "13",
doi = "10.3389/fncel.2013.00123",
language = "English (US)",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",
number = "JUL",

}

TY - JOUR

T1 - Impact of trichostatin A and sodium valproate treatment on post-stroke neurogenesis and behavioral outcomes in immature mice

AU - George, S.

AU - Kadam, S. D.

AU - Irving, N. D.

AU - Markowitz, G. J.

AU - Raja, S.

AU - Kwan, A.

AU - Tu, Y.

AU - Chen, H.

AU - Rohde, Charles A

AU - Smith, D. R.

AU - Comi, Anne Marie Spalding

PY - 2013/7/13

Y1 - 2013/7/13

N2 - Stroke in the neonatal brain frequently results in neurologic impairments including cognitive disability. We investigated the effect of long-term sodium valproate (valproate) and Trichostatin A (TSA) treatment upon post-stroke neurogenesis in the dentate gyrus (DG) of stroke-injured immature mice. Decreased or abnormal integration of newborn DG neurons into hippocampal circuits can result in impaired visual-spatial function, abnormal modulation of mood-related behaviors, and the development of post-stroke epilepsy. Unilateral carotid ligation of P12 CD1 mice was followed by treatment with valproate, TSA, or vehicle for 2 weeks, BrdU administration for measurement of neurogenesis, and perfusion at P42 or P60. Behavior testing was conducted from P38-42. No detrimental effects on behavior testing were noted with TSA treatment, but mildly impaired cognitive function was noted with valproate-treated injured animals compared to normal animals. Significant increases in DG neurogenesis with both TSA and valproate treatment were noted with later administration of BrdU. Increased mortality and impaired weight gain was noted in the valproate-treated ligated animals, but not in the TSA52 treated animals. In summary, the impact of HDAC inhibition upon post-stroke SGZ neurogenesis is likely to depend on the age of the animal at the time point when neurogenesis is assessed, duration of HDAC inhibition before BrdU labeling, and/or the stage in the evolution of the injury.

AB - Stroke in the neonatal brain frequently results in neurologic impairments including cognitive disability. We investigated the effect of long-term sodium valproate (valproate) and Trichostatin A (TSA) treatment upon post-stroke neurogenesis in the dentate gyrus (DG) of stroke-injured immature mice. Decreased or abnormal integration of newborn DG neurons into hippocampal circuits can result in impaired visual-spatial function, abnormal modulation of mood-related behaviors, and the development of post-stroke epilepsy. Unilateral carotid ligation of P12 CD1 mice was followed by treatment with valproate, TSA, or vehicle for 2 weeks, BrdU administration for measurement of neurogenesis, and perfusion at P42 or P60. Behavior testing was conducted from P38-42. No detrimental effects on behavior testing were noted with TSA treatment, but mildly impaired cognitive function was noted with valproate-treated injured animals compared to normal animals. Significant increases in DG neurogenesis with both TSA and valproate treatment were noted with later administration of BrdU. Increased mortality and impaired weight gain was noted in the valproate-treated ligated animals, but not in the TSA52 treated animals. In summary, the impact of HDAC inhibition upon post-stroke SGZ neurogenesis is likely to depend on the age of the animal at the time point when neurogenesis is assessed, duration of HDAC inhibition before BrdU labeling, and/or the stage in the evolution of the injury.

KW - Anticonvulsants

KW - Behavioral outcomes

KW - Hippocampal neurogenesis

KW - Histone deacetylase inhibitors

KW - Neonatal stroke

KW - Trichostatin A

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=84880157131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880157131&partnerID=8YFLogxK

U2 - 10.3389/fncel.2013.00123

DO - 10.3389/fncel.2013.00123

M3 - Article

C2 - 23966909

AN - SCOPUS:84880157131

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

IS - JUL

ER -